USPTO serial 98785682
AUTOMATING BETTER BIOLOGY
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 7, 2025
- Examiner
- BEAUDRY-TORRES, FAITH
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with AUTOMATING BETTER BIOLOGY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Maury M. Tepper, III
Maury M. Tepper, III Tepper & Eyster, PLLC3724 Benson DriveRaleigh, NC 27609United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 007 | Industrial machines and manufacturing equipment, namely, bioreactors for use in manufacturing biopharmaceuticals in the field of cell cultures, cell therapy, and gene therapy; racks specially adapted as components for bioreactors for use in manufacturing biopharmaceuticals; racks specially adapted for holding cell culture, cell therapy or gene therapy manufacturing equipment; structural components of bioreactors for use in manufacturing biopharmaceuticals comprised of bellows, bags, vessels, bottles and containers for storing, containing, dispensing or extracting fluids, stem cells, cell cultures or cell culture media to or from industrial machines and manufacturing equipment sold as a unit; replacement and structural parts, including disposable parts, for industrial manufacturing equipment in the nature of bioreactors for use in manufacturing biopharmaceuticals in the field of cell cultures, cell therapy, and gene therapy; plastic pipe connectors being parts of industrial manufacturing apparatus in the nature of bioreactors for use in manufacturing biopharmaceuaticals in the field of cell culture, cell therapy or gene therapy; sterile connectors, namely, plastic pipe connectors and needle-based connectors made of plastic being parts of industrial manufacturing apparatus in the nature of bioreactors for use in manufacturing biopharmaceuaticals in the field of cell culture, cell therapy or gene therapy; industrial incubators in the nature of bioreactors for use in manufacturing biopharmaceuticals in the field of cell cultures, cell therapy, and gene therapy; industrial incubators in the nature of bioreactors for use in manufacturing and maintaining of biopharmaceuticals in the field of cell cultures; industrial apparatus, namely, bioreactors for use in manufacturing biopharmaceuticals, consisting primarily of a handling unit for creating a controlled environment for cell therapy and gene therapy manufacturing; machines for adding or removing fluids to or from industrial manufacturing bioreactors for cell and gene therapies; replacement parts and structural parts for all the aforesaid goods | ACTIVE | — |
| 009 | downloadable computer software and downloadable computer software applications for controlling, monitoring, programming, communicating with, operating and adjusting apparatus and equipment for cell culture, cell therapy or gene therapy; downloadable computer software and downloadable computer software applications for controlling, monitoring, programming and adjusting environmental conditions for cell culture, cell therapy or gene therapy; downloadable computer software and downloadable computer software applications for logging data in relation to cell culture, cell therapy or gene therapy; downloadable computer software and downloadable computer software applications for monitoring patient health; downloadable computer software and downloadable computer software applications for providing information on cell culture, cell therapy or gene therapy; downloadable databases of data in the field of cell culture, cell therapy, and gene therapy; disposable structural parts for bioreactors for cell culturing; cassettes specially adapted for bioreactors for cell culturing; disposable cassettes specially adapted for bioreactors for cell culturing; cassettes specially adapted for industrial bioreactors for cell culturing; disposable cassettes specially adapted for industrial bioreactors for cell culturing; disposable scientific equipment and apparatus for cell culture, cell therapy or gene therapy, namely, bioreactors for laboratory use; plastic pipe connectors being parts of scientific apparatus and equipment in the nature of bioreactors for research in the field of cell cultures, cell therapy or gene therapy; plastic pipe connectors being parts of scientific apparatus in the nature of bioreactors for research in the field of cell culture, cell therapy or gene therapy; sterile connectors, namely, plastic pipe connectors and needle-based connectors made of plastic being parts of scientific apparatus and equipment in the nature of bioreactors for research in the field of cell cultures, cell therapy or gene therapy; sterile connectors, namely, plastic pipe connectors and needle-based connectors made of plastic being parts of scientific apparatus in the nature of bioreactors for research in the field of cell cultures, cell therapy or gene therapy; bellows specially adapted for bioreactors for laboratory use for storing, containing, dispensing or extracting fluids, stem cells, cell cultures or cell culture media to or from scientific apparatus and equipment; bellows specially adapted for bioreactors for laboratory use for storing, containing, dispensing or extracting fluids, stem cells, cell cultures or cell culture media to or from scientific apparatus and equipment for cell culture, cell therapy or gene therapy; bags specially adapted for bioreactors for laboratory use for storing, containing, dispensing or extracting fluids, stem cells, cell cultures or cell culture media to or from scientific apparatus and equipment; bags specially adapted for bioreactors for laboratory use for storing, containing, dispensing or extracting fluids, stem cells, cell cultures or cell culture media to or from scientific apparatus and equipment for cell culture, cell therapy or gene therapy; flexible containers specially adapted for bioreactors for laboratory use for storing, containing, dispensing or extracting fluids, stem cells, cell cultures or cell culture media to or from scientific apparatus and equipment; flexible specially adapted for bioreactors for laboratory use containers for storing, containing, dispensing or extracting fluids, stem cells, cell cultures or cell culture media to or from scientific apparatus and equipment for cell culture, cell therapy or gene therapy; compressible containers specially adapted for bioreactors for laboratory use for storing, containing, dispensing or extracting fluids, stem cells, cell cultures or cell culture media to or from scientific apparatus and equipment; compressible containers specially adapted for bioreactors for laboratory use for storing, containing, dispensing or extracting fluids, stem cells, cell cultures or cell culture media to or from scientific apparatus and equipment for cell culture, cell therapy or gene therapy; vessels, bottles and containers being scientific equipment specially adapted for bioreactors for laboratory use for storing, containing, dispensing or extracting fluids, stem cells, cell cultures or cell culture media to or from scientific apparatus and equipment; vessels, bottles and containers being scientific equipment specially adapted for bioreactors for laboratory use for storing, containing, dispensing or extracting fluids, stem cells, cell cultures or cell culture media to or from scientific apparatus and equipment for cell culture, cell therapy or gene therapy; incubators for cell culture, cell therapy or gene therapy; incubators for maintaining cell cultures; bioreactor arrays consisting of bioreactors for laboratory use; multiplexed bioreactor systems consisting primarily of bioreactors for laboratory use; aseptic filing and sealing machines being components of bioreactors for laboratory use; bioreactors for cell culturing; Bioreactors for laboratory use in the field of cell and gene therapy; scientific apparatus, namely, bioreactors for laboratory use, consisting primarily of a handling unit for creating a controlled environment for cell cultures, cell therapy or gene therapy processing; fixtures especially made for laboratories, namely, cell culture ventilation hoods and bio-safety cabinets for cell culture, cell therapy, and gene therapy; laboratory equipment, namely, water baths for laboratory use and cell culture vessels in the nature of glassware for cell cultures, cell therapy, and gene therapy; disposable bioreactors for cell culturing; scientific equipment for filling bioreactors, namely pipettes for laboratory use; replacement parts and structural parts for all the aforesaid | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Oribiotech Limited
- Other trademarks owned by Oribiotech Limited
- Other trademarks owned by Oribiotech Limited
- Other trademarks in Class 007
- Other trademarks in Class 009
- Similar marks named AUTOMATING BETTER BIOLOGY
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 7, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Oct 7, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 19, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 19, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 13, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 14, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 12, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 12, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 12, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 14, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 14, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 14, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 10, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 9, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 4, 2024 | NWAP | NEW APPLICATION ENTERED | — |